Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Zentalis Pharmaceuticals (ZNTL) Receivables - Other (2022 - 2023)

Zentalis Pharmaceuticals has reported Receivables - Other over the past 2 years, most recently at $7.9 million for Q1 2023.

  • Quarterly results put Receivables - Other at $7.9 million for Q1 2023, up 236.8% from a year ago — trailing twelve months through Mar 2023 was $7.9 million (up 236.8% YoY), and the annual figure for FY2022 was $5.9 million, changed.
  • Receivables - Other for Q1 2023 was $7.9 million at Zentalis Pharmaceuticals, up from $5.9 million in the prior quarter.
  • Over the last five years, Receivables - Other for ZNTL hit a ceiling of $7.9 million in Q1 2023 and a floor of $2.3 million in Q1 2022.